Synergistic Occurrence of EGFR, ALK, and KRAS Gene Mutations in a Patient with Non-small Cell Lung Cancer (Adenocarcinoma)
Author(s) -
Dinesh Chandra Doval,
Rupal Tripathi,
Kumardeep Dutta Choudhury,
Ajay Sharma,
Ullas Batra,
Anurag Mehta,
PS Choudhury
Publication year - 2019
Publication title -
indian journal of medical sciences
Language(s) - English
Resource type - Journals
eISSN - 1998-3654
pISSN - 0019-5359
DOI - 10.25259/ijms_3_2019
Subject(s) - medicine , kras , adenocarcinoma , lung cancer , malignancy , oncology , disease , chemotherapy , adenocarcinoma of the lung , cancer , lung , stage (stratigraphy) , cancer research , colorectal cancer , biology , paleontology
Lung cancer is a commonly diagnosed malignancy. Adenocarcinoma, a subgroup of non-small cell lung cancer, is the commonest form and presents in an advanced stage of the disease, leaving a limited treatment option. Response to the standard chemotherapy regimens is overall poor. We present a case of synergistic occurrence of triple gene mutations in a patient with well-diff erentiated adenocarcinoma lung treated at a tertiary cancer care center in North India.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom